BioWorld - Friday, May 1, 2026

lepu biopharma co. ltd.

21 items

hypercholesterolemia

21 items

pde4 inhibitors

21 items

2022

21 items

final guidance

21 items

lyme disease

21 items

polycythemia vera

21 items

iso 13485

21 items

knee osteoarthritis

21 items

sana biotechnology inc.

21 items

hdac inhibitors

21 items

national cancer institute

21 items

blood tests

21 items

zika virus

21 items

samd

21 items

university of pittsburgh

21 items

hiv vaccine

21 items

lung adenocarcinoma

21 items

sitc 2025

21 items

amylyx pharmaceuticals inc.

21 items